Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GEOVAX LABS, INC. (GOVX)

  • Technical Exchange News
  • July 07, 2026, 01:52 UTC
  • 1
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

ESTRELLA IMMUNOPHARMA, INC. (ESLA)

  • Technical Exchange News
  • July 07, 2026, 01:52 UTC
  • 3
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

ESTRELLA IMMUNOPHARMA, INC. (ESLAW)

  • Technical Exchange News
  • July 07, 2026, 01:52 UTC
  • 3
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

ESLA attributes changed

  • Technical Exchange News
  • July 07, 2026, 01:52 UTC
  • 3
  • 0 comments

ESLA attributes changed: Attr: Fin_status D -> N;

Comment Full text

ESLAW attributes changed

  • Technical Exchange News
  • July 07, 2026, 01:52 UTC
  • 1
  • 0 comments

ESLAW attributes changed: Attr: Fin_status D -> N;

Comment Full text

CGTL attributes changed

  • Technical Exchange News
  • July 07, 2026, 01:52 UTC
  • 3
  • 0 comments

CGTL attributes changed: Attr: Fin_status N -> D;

Comment Full text

BAYAU attributes changed

  • Technical Exchange News
  • July 07, 2026, 01:52 UTC
  • 2
  • 0 comments

BAYAU attributes changed: Attr: Fin_status D -> N;

Comment Full text

BAYAR attributes changed

  • Technical Exchange News
  • July 07, 2026, 01:52 UTC
  • 3
  • 0 comments

BAYAR attributes changed: Attr: Fin_status D -> N;

Comment Full text

BAYA attributes changed

  • Technical Exchange News
  • July 07, 2026, 01:52 UTC
  • 3
  • 0 comments

BAYA attributes changed: Attr: Fin_status D -> N;

Comment Full text

GEOVAX LABS, INC. (GOVX)

  • Technical Exchange News
  • July 07, 2026, 01:48 UTC
  • 3
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 54
  • 55
  • 56
  • 57
  • 58
  • Next

Search

News categories

  • Technical Exchange News(14094)
  • Event(6229)
  • SEC News(359824)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(218099)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin